Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR08 in Children with ADHD
NCT01876719Phase 2Completed
- Start
- Jun 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AR08 in attention deficit hyperactivity disorder (ADHD). Started Jun 2013; status: completed.
02
Drugs
AR08
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01876719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876719.